The biotech sector exceeded market expectations through the grim twelve months. This was the second-highest number of medicines approved in a single year. In 2021, billions of dollars worth of the money will be spent by governments across the world on biotech companies mass-producing COVID-19 vaccines, like Moderna, Inc. Medicine prices are skyrocketing, and there are several world governments debating policies to lower the costs of drugs essential to the survival of terminally ill patients. The biotech sector is also becoming a large industry that offers a lot of jobs and growth opportunities. For example, the life sciences industry in Florida alone supports more than 83,000 people.
Insider Monkey draws a list of 10 Best Biotech Stocks Under $6 in 2021. Starting with MediciNova, Inc. The products that the company is developing include an oral anti-inflammatory and neuroprotective agent for treating neurological disorders and a selective beta-2-adrenergic receptor agonist to treat acute exacerbations of asthma. One of Voyager Therapeutics, Inc. offers is VY-AADC, an open-label trial drug for the treatment of Parkinson’s disease. It also drugs in the pipeline to treat amyotrophic lateral sclerosis, Huntington’s disease, Friedreich’s ataxia, and tauopathies, including Alzheimer’s disease, progressive supranuclear palsy, and frontotemporal dementia. One of the products that OncoCyte Corporation offers is named DetermaRx, a molecular test for early-stage adenocarcinoma of the lung, and DetermaIO, a proprietary gene expression assay. The company said that the results added value to the findings of drug tests related to lung and breast cancers. GeoVax Labs, Inc. is involved in the development of vaccines against COVID-19, human immunodeficiency virus (HIV); Zika virus; malaria; Ebola virus, Sudan virus, Marburgvirus, and Lassa virus, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers. It has collaborative agreements with many laboratories and medical institutes across the United States, including the National Institute of Allergy and Infectious Diseases of the National Institutes of Health, the HIV Vaccines Trial Network, and the Center for Disease Control and Prevention. Bellus Health Inc. is a Canada-based company that develops medicines to treat chronic cough and other hypersensitization disorders. One of the leading projects of the company is the drug BLU-5937, an oral small molecule antagonist of the P2X3 receptor, which is in Phase II clinical trial for the treatment of chronic cough and chronic pruritus. For more facts, read The 10 Best Biotech Stocks Under $6 in 2021.
